Abstract Symposia Monday

Monday, July 1, 13.00-14.15

AS-01: Cardiovascular Disease

  • Nanomedicines for cardiovascular disease
    Samuel Wickline

AS-02: Assays for antithrombotic drugs

  • Assays for antithrombotic drugs
    Wayne Chandler

AS-03: Platelet Interactions

  • Homo- and heterotypic platelet interactions
    Anne Angelillo-Scherrer

AS-04: Inflammation and Coagulation in Atherosclerosis

  • The coagulation-inflammation axis in atherosclerosis
    Julian Borissoff

AS-05: Hormones and Thrombosis

  • Exogenous hormones and thrombosis
    Mary Cushman

AS-06: Post-thrombotic Syndrome

  • Post-thrombotic syndrome: evidence-based update on prevention and treatment
    Susan Kahn

As-07: Upcoming Anticoagulants

  • Rational design of future low molecular weight anticoagulant medications: can we get assistance from novel computational drug discovery methods?
    Bruno Villoutreix

AS-08: Antiphospholipid Syndrome

  • Serology and pathophysiology of the antiphospholipid syndrome
    Flip de Groot

AS-09: Flow and von Willebrand Factor

  • Aberrant flow and activation of von Willebrand Factor
    Timothy Springer

 AS-10: Coagulation and Inflammaton

  • Hemostatic factors and innate immunity
    Jay Degen

AS-11: New genetic determinants of venous thrombosis

  • New genetic determinants of venous thrombosis
    Tetsuhito Kojima

AS-12: Late breaking abstracts